Pierre Thadee Victor Kemula
CIK: 0002119332
Transaction Breakdown
Open Market Buys (P)3 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AGMB
AgomAb Therapeutics NV
Officer
Discretionary Trading P&L
Holdings
About Kemula Pierre Thadee Victor
Kemula Pierre Thadee Victor (SEC CIK 0002119332) files insider reports with the SEC as Chief Financial Officer of AgomAb Therapeutics NV (AGMB).
Signal8 holds 2 ownership filings by Kemula Pierre Thadee Victor (1 Form 3, 1 Form 4), filed between Mar 18, 2026 and Oct 7, 2026. Those filings report 3 transactions, the latest on Oct 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kemula Pierre Thadee Victor's filings is in ANTWERPEN.
Recent filings by Kemula Pierre Thadee Victor
- Oct 6, 2026: Open-market purchases of AGMB shares (3 lines, Form 4, code P).
Other insiders filing for AgomAb Therapeutics NV (AGMB)
- Epstein David R, Director
- Knotnerus Tim Jasper, Chief Executive Officer
- Garcia Marino, Director
- Patel Naimish, Director
- Bond Colin Michael, Director
- Hammer Ohad, Director